Le Final Event du projet européen Cobra (Cooperative Brachytherapy) concernant une solution robotisée et contrôlée en temps réel par IRM pour la biopsie et la curiethérapie des tumeurs des tissus mous se tiendra le 24 juin prochain de 12h00 à 17h00 au campus Université de Lille Sciences et Technologies de Villeneuve d’Ascq (59)
COOPERATIVE BRACHYTHERAPY PROJECT FINAL EVENT
24th of June 2022 from 12am to 5pm
Poly'tech Lille, Av. Paul Langevin, 59655 Villeneuve d'Ascq
We have the greatest pleasure to invite you to the CoBra Project Final Event during which you will be presented the development of the COBRA real time MR in-bore guided robotic solution for soft tissue tumor biopsy and Brachytherapy treatment.
During the event, we will offer you the opportunity to see and test the CoBra robot within the Cristal laboratory facilities.
ONLINE PARTICIPATION AVAILABLE
Provisional program (CET time):
12 am - 1 pm
Welcome Lunch (regristration needed)
1 pm - 3:00 pm
- Introduction and partner presentation (15min)
- Clinical background and objectives (10min)
- CoBra technologies : feedback on the project modules development and results (1 hour)
- Feedback on the animal tests (10min)
- Social-Medical-Economic impacts (10min)
- Industrial opportunities of the project (10min)
3:00 pm - 3:45 pm
Round table on the perspective of MRI guided Robot and automated Biopsy and brachytherapy solutions
3:45 pm - 5pm
Laboratory visit, robot demonstration and test
About the CoBra project :
The Cooperative Brachytherapy (CoBra) project aims to improve the quality of both Biopsy and brachytherapy treatment of soft tissue localized tumors with a first focus on prostate tumor, the fourth most common cancer in Europe (both sexes, all ages) and the first most common cancer in males. The CoBra project develop a new in Bore MRI guided robotic solution combining a steerable needle system or an automatic biopsy module. With such Real Time live MRI compatibility, the CoBra Robot will combine the precision of the MRI imaging and the capacity to control in real time, the position of the biopsy needle or the radioactive seed implantation as well as the real-time radiation dose calculation and control.
This technology will greatly improve the tumor biopsy and radiation treatment accuracy and efficiency and increase the potential treated volume, ultimately improving the patient cure rates and quality of life while minimizing side effects. Started in 2018, The CoBra project has reached now the prototype stage with the first tests on live animal patient ongoing in 2022.